we know the disease might be halted by this process. To get vision improvement this early is absolutely staggering news. The market doesn’t really understand this point. Lifelong drug, vision returning, every patient will want this. 1B US in potential sales. Go figure. A 20-30 bagger on this drug alone over 3 years.
Ann: RP11 Clinical Trial Update, page-9
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.8¢ |
Change
-0.003(1.92%) |
Mkt cap ! $594.9M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $203.1K | 1.598M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 132660 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 321546 | 5 |
View Market Depth
| Last trade - 14.37pm 11/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |